COMP <GO>
MTEX vs MRK // REVENUE GROWTH (YOY)
Mannatech Incorporated (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: MTEX 2
— MRK 8
▲ REVENUE GROWTH (YOY) LEADER: MRK
LAST: $8.33 (-2.23%) • MKT CAP: $16.1M
revenue-growth
-8.30%
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
revenue-growth
1.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MTEX VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MTEX | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.90% | 74.80% | +0.10 | MTEX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 20.70% | -55.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 3.42% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -0.40% | 34.30% | -34.70 | MRK | /operating-margins <GO> |
| Net Profit Margin | -14.10% | 28.10% | -42.20 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -8.30% | 1.30% | -9.60 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.25 | 5.19 | -1.94 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.8 | 51.7 | +3.10 | MTEX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.1M | $361.02B | -$361.01B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MTEX REV | MRK REV | MTEX GROSS % | MRK GROSS % | MTEX FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $108.0M | $65.01B | 74.9% | 74.8% | -$4.3M | $12.36B |
| FY 2024 | $117.9M | $64.17B | 77.6% | 76.3% | $2.0M | $18.10B |
| FY 2023 | $132.0M | $60.12B | — | — | -$2.4M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MTEX // BETA —
MRK // BETA 0.92